{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T09:57:42Z","timestamp":1760781462340,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.jsbmb.2004.06.004","type":"journal-article","created":{"date-parts":[[2004,10,28]],"date-time":"2004-10-28T14:44:17Z","timestamp":1098974657000},"page":"29-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["6-[2-(Adamantylidene)-hydroxybenzoxazole]-O-sulfamate, a steroid sulfatase inhibitor for the treatment of androgen- and estrogen-dependent diseases"],"prefix":"10.1016","volume":"92","author":[{"given":"Andreas","family":"Billich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef G.","family":"Meingassner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Nussbaumer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Desrayaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Winiski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwin","family":"Schreiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2004.06.004_bib1","doi-asserted-by":"crossref","first-page":"C113","DOI":"10.1016\/0303-7207(91)90116-A","volume":"78","author":"Labrie","year":"1991","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib2","first-page":"51","article-title":"Sulphatase inhibitors: the rationale for the development of a new endocrine therapy","volume":"45","author":"Reed","year":"1993","journal-title":"Rev. Endocrine Rel. Cancer."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib3","first-page":"673","article-title":"Steroid sulphatase inhibitors: a new endocrine therapy","volume":"19","author":"Reed","year":"1994","journal-title":"Drugs Future"},{"key":"10.1016\/j.jsbmb.2004.06.004_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0022-4731(89)90077-0","article-title":"Importance of estrogen sulfates in breast cancer","volume":"34","author":"Pasqualini","year":"1989","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0960-0760(99)00082-5","article-title":"Estrone sulfatase versus estrone sulfotransferase in human breast cancer: potential clinical applications","volume":"69","author":"Pasqualini","year":"1999","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/BF02967607","article-title":"In situ production of estrogens in human breast carcinoma","volume":"9","author":"Suzuki","year":"2002","journal-title":"Breast Cancer"},{"key":"10.1016\/j.jsbmb.2004.06.004_bib7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0960-0760(03)00353-4","article-title":"Steroid sulphatase inhibitors for breast cancer therapy","volume":"86","author":"Purohit","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0960-0760(00)00060-1","article-title":"Elevated steroid sulfatase expression in breast cancers","volume":"73","author":"Utsumi","year":"2000","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib9","first-page":"2762","article-title":"Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma","volume":"63","author":"Suzuki","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0960-0760(03)00357-1","article-title":"Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients","volume":"86","author":"Nakata","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib11","first-page":"377","article-title":"Steroid sulfatase expression is an independent predictor of recurrence in human breast cancer","volume":"59","author":"Utsumi","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib12","first-page":"2288","article-title":"High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer","volume":"9","author":"Miyoshi","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib13","first-page":"1683","article-title":"Dehydroepiandrosterone sulfate estrogenic action at its physiological plasma concentration in human breast cancer cell lines","volume":"18","author":"Le Bail","year":"1998","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0960-0760(00)00077-7","article-title":"Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors","volume":"73","author":"Billich","year":"2000","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib15","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1517\/13543776.13.5.605","article-title":"Steroid sulfatase inhibitors","volume":"13","author":"Nussbaumer","year":"2003","journal-title":"Expert Opinion Ther. Patents"},{"key":"10.1016\/j.jsbmb.2004.06.004_bib16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2174\/0929867023371210","article-title":"Review of estrone sulfatase and its inhibitors \u2013 an important new target against hormone dependent breast cancer","volume":"9","author":"Ahmed","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/med.20008","article-title":"Steroid sulfatase inhibitors","volume":"24","author":"Nussbaumer","year":"2004","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ijc.2910630119","article-title":"In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone-3-O-sulphamate","volume":"63","author":"Purohit","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jsbmb.2004.06.004_bib19","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/(SICI)1097-0215(20000215)85:4<584::AID-IJC22>3.0.CO;2-Q","article-title":"The effect of 2-methoxyoestrone-3-O-sulphamate on the growth of breast cancer cells and induced mammary tumours","volume":"85","author":"Purohit","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jsbmb.2004.06.004_bib20","first-page":"3394","article-title":"In vivo inhibition of estrone sulfatase activity and growth of nitrosomethylurea-induced mammary tumors by 667 COUMATE","volume":"60","author":"Purohit","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0039-128X(02)00118-6","article-title":"Steroidal oxathiazine inhibitors of estrone sulfatase","volume":"68","author":"Peters","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2004.06.004_bib22","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0039-128X(02)00030-2","article-title":"Inhibition of steryl sulfatase activity in LNCaP human prostate cancer cells","volume":"67","author":"Selcer","year":"2002","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2004.06.004_bib23","first-page":"95","article-title":"The metabolism of [14C]dehydroepiandrosterone by human skin in vitro","volume":"27","author":"Faredin","year":"1970","journal-title":"Acta Med. Acad. Sci. Hung."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib24","first-page":"529","article-title":"Cutaneous production of potent androgens from dehydroepiandrosterone in adult women","volume":"10","author":"Voigt","year":"1982","journal-title":"IRSC Med. Sci."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib25","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1523-1747.2002.00613.x","article-title":"Cutaneous androgen metabolism: basic research and clinical perspectives","volume":"119","author":"Chen","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib26","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/jcem-1-7-570","article-title":"Male hormone substance: a prime factor in acne","volume":"1","author":"Hamilton","year":"1941","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib27","first-page":"524","article-title":"The androgen control of sebum production: studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity","volume":"76","author":"Imperato-McGinley","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib28","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/archderm.1992.01680200055006","article-title":"Sebaceous gland activity and serum dehydroepiandrosterone sulfate levels in boys and girls","volume":"128","author":"Stewart","year":"1992","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0022-3476(97)70307-X","article-title":"Predictors of severity of acne vulgaris in young adolescent girls: results of a five-year longitudinal study","volume":"130","author":"Lucky","year":"1997","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib30","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1001\/archderm.1994.01690030040006","article-title":"Acne vulgaris in premenarchal girls","volume":"130","author":"Lucky","year":"1994","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib31","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM198304283081701","article-title":"Androgen excess in cystic acne","volume":"308","author":"Marynick","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2133.1995.tb02623.x","article-title":"Clinical, ultrasound and hormonal markers of androgenicity in acne vulgaris","volume":"133","author":"Walton","year":"1995","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib33","first-page":"99","article-title":"Immunohistochemical localization of steroid sulfatase in acne lesions: implications for the contribution of dehydroepiandrosterone sulfate to the pathogenesis of acne","volume":"53","author":"Billich","year":"2000","journal-title":"Horm. Res."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib34","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1021\/jm020878w","article-title":"2-Substituted 4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase","volume":"45","author":"Nussbaumer","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib35","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1016\/j.bmcl.2003.09.050","article-title":"6-[2-(Adamantylidene)-hydroxybenzoxazole]-O-sulfamate: a potent non-steroidal irreversible inhibitor of human steroid sulfatase","volume":"3","author":"Schreiner","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0003-9861(76)90339-8","article-title":"Solubilization and partial purification of steroid sulfatase from rat liver: characterization of estrone sulfatase","volume":"174","author":"Iwamori","year":"1976","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib37","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.106.3.761","article-title":"Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line","volume":"106","author":"Boukamp","year":"1988","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib38","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0378-5173(00)00665-7","article-title":"Comparison of human skin or epidermis models with human and animal skin in in vitro percutaneous absorption","volume":"215","author":"Schmook","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib40","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0022-4731(84)90134-1","article-title":"New assay for steroid sulfatase (EC 3.1.6.2) and its application for studies of human placental and skin sulfatase","volume":"20","author":"Rabe","year":"1984","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib41","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1172\/JCI110153","article-title":"Steroid sulfatase of human leukocytes and epidermis and the diagnosis of recessive X-linked ichthyosis","volume":"67","author":"Epstein","year":"1981","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib42","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"2999","article-title":"Steroid sulfatase deficiency and X-linked ichthyosis","author":"Ballabio","year":"1995"},{"key":"10.1016\/j.jsbmb.2004.06.004_bib43","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1523-1747.2003.22258.x","article-title":"Basis for abnormal desquamation and permeability barrier dysfunction in RXLI","volume":"122","author":"Elias","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib44","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1039\/c39860001582","article-title":"The anionic sulfonylamine mechanism in the hydrolysis of aryl sulfamates","volume":"21","author":"Thea","year":"1986","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib45","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1021\/jm030926s","article-title":"Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-O-sulfamates, potent inhibitors of human steroid sulfatase","volume":"46","author":"Nussbaumer","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2004.06.004_bib46","first-page":"17","article-title":"Development of an oral formulation for oestrone 3-O-sulphamate, a potent sulphatase inhibitor","volume":"2","author":"Sahm","year":"1996","journal-title":"Pharm. Sci."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076004003231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076004003231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:48:58Z","timestamp":1760734138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076004003231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":46,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0960076004003231"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2004.06.004","relation":{},"ISSN":["0960-0760"],"issn-type":[{"type":"print","value":"0960-0760"}],"subject":[],"published":{"date-parts":[[2004,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"6-[2-(Adamantylidene)-hydroxybenzoxazole]-O-sulfamate, a steroid sulfatase inhibitor for the treatment of androgen- and estrogen-dependent diseases","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2004.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}